Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Loading history...
Latest & greatest articles for pressure ulcer
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pressure ulcer or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on pressure ulcer and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com
A comprehensive program to prevent pressureulcers in long-term care: exploring costs and outcomes A comprehensive program to prevent pressureulcers in long-term care: exploring costs and outcomes A comprehensive program to prevent pressureulcers in long-term care: exploring costs and outcomes Lyder C H, Shannon R, Empleo-Frazier O, McGeHee D, White C Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains (...) a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The authors assessed comprehensive protocols of care (SOLUTIONS, ConvaTec, a Bristol-Myers Squibb Company) for the prevention of pressureulcers in long-term care. The protocols focused on risk factors identified in accordance with the Braden Scale. The comprehensive programme for pressureulcer preventioncomprised
Is noncontact normothermic wound therapy cost effective for the treatment of stages 3 and 4 pressureulcers Is noncontact normothermic wound therapy cost effective for the treatment of stages 3 and 4 pressureulcers Is noncontact normothermic wound therapy cost effective for the treatment of stages 3 and 4 pressureulcers Macario A, Dexter F Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of noncontact normothermic wound therapy (NNWT; Warm-Up Therapy, Augustine Medical Inc.) for the treatment of stages 3 and 4 pressureulcers. NNWT was administered three times a day for one hour. In addition, all of the patients received standard care. Standard care consisted of cleansing the wound, using a pressure-reducing
Pressureulcer prevention and treatment following spinal cord injury. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding for the National
Air-fluidized beds used for treatment of pressureulcers in the home environment Air-fluidized beds used for treatment of pressureulcers in the home environment Air-fluidized beds used for treatment of pressureulcers in the home environment ECRI Authors' objectives To determine the effectiveness of air-fluidised beds and group 2 support surfaces, as defined by the Centers for Medicare and Medicaid Services, for the treatment of stage III or IV pressureulcers in the home and other settings (...) eligible for inclusion. Specific interventions included in the review Controlled studies of air-fluidised beds or group 2 support surfaces in the home setting were eligible for inclusion in the review. Owing to the paucity of research in the home setting, the authors relaxed their inclusion criteria and included studies that were not in the home setting. Participants included in the review Studies that included patients with stage III or IV pressureulcers, which presented results separately from those
Translating pressureulcer guidelines into practice: it's harder than it sounds Translating pressureulcer guidelines into practice: it's harder than it sounds Translating pressureulcer guidelines into practice: it's harder than it sounds Xakellis G C, Frantz R A, Lewis A, Harvey P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study examined a protocol aimed at reducing the incidence and time to healing of pressureulcers in patients in a long-term care facility. The protocol consisted of identifying patients at risk of a pressureulcer, the regular repositioning of patients with limited mobility, and providing support surfaces such as mattress overlays, chair cushions and padding for a bony prominence. Type
Cost and cost effectiveness of venous and pressureulcer protocols of care Cost and cost effectiveness of venous and pressureulcer protocols of care Cost and cost effectiveness of venous and pressureulcer protocols of care Kerstein M D, Gemmen E, van Rijswijk L, Lyder C H, Phillips T, Xakellis G, Golden K, Harrington C Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The health technologies in the study were represented by protocols of wound care for pressureulcer and venous ulcer. The three care protocols for pressureulcer were saline moistened gauze, hydrocolloid Comfeel dressing, and hydrocolloid DuoDERM dressing. The three care protocols for venous ulcer were paraffin-, saline-, or zinc oxide-impregnated gauze
Effectiveness of special dressings in the treatment of pressure and leg ulcers. IPE-01/28 (Public report) Effectiveness of special dressings in the treatment of pressure and leg ulcers. IPE-01/28 (Public report) Effectiveness of special dressings in the treatment of pressure and leg ulcers. IPE-01/28 (Public report) Bouza Alvarez C, Sanz de Leon O M, Amate Blanco J M Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation (...) of the quality of this assessment has been made for the HTA database. Citation Bouza Alvarez C, Sanz de Leon O M, Amate Blanco J M. Effectiveness of special dressings in the treatment of pressure and leg ulcers. IPE-01/28 (Public report) Madrid: Agencia de Evaluacion de Tecnologias Sanitarias (AETS). Informe de Evaluacion de Tecnologias Sanitarias No.28. 2001 Authors' objectives To evaluate the effectiveness and cost-effectiveness of modern dressings in the treatment of pressureulcers and leg ulcers
Constant force technology versus low-air-loss therapy in the treatment of pressureulcers "Constant force technology" versus low-air-loss therapy in the treatment of pressureulcers "Constant force technology" versus low-air-loss therapy in the treatment of pressureulcers Branom R, Rappl L M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions (...) followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The PressureGuard CFT (Constant Force Technology) mattress by Span-America Medical Systems Inc., subsequently referred to as the "study mattress", and a low-air-loss (LAL) mattress were compared. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study examined patients with stage III or IV pressureulcers on the trunk or pelvis
Pressure relieving interventions for preventing and treating diabetic foot ulcers. Foot ulceration is thought to affect 15% of all people with diabetes at some time during their life.To assess the effectiveness of pressure relieving interventions in the prevention and treatment of diabetic foot ulcers.Searches of 19 databases, hand searching of journals, bibliographies and identification of unpublished work by written communication with recognised experts in the diabetic foot.Randomised (...) controlled trials evaluating pressure relieving interventions either in the prevention or the treatment of diabetic foot ulcers. There was no restriction on articles/trials based on language or publication status.Data extraction and assessment of study quality was undertaken by two reviewers independently. Each trial was analysed separately, no pooling of results was possible due to the difference in patients, comparisons and outcomes.Prevention 4 RCTs of pressure relieving interventions were identified
Prevention of pressureulcers Prevention of pressureulcers Prevention of pressureulcers Bernath V Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bernath V. Prevention of pressureulcers. Centre for Clinical Effectiveness (CCE). Evidence Centre Evidence Report. 2000 Authors' objectives This aim of this report was to assess the most effective methods (...) of pressureulcer prevention in patients in long term intensive care. Authors' conclusions A recently published evidence based guidelines document on pressureulcer risk assessment and prevention was located. The guidelines are still the 'first version of the final draft', available for comment until 15 September 2000. The expected date of the revised final draft is December 2000. The guideline is evidence-linked, rather than evidence-based. As there was insufficient evidence to guide all clinical
Cost, efficacy, efficiency and tolerability of collagenase ointment versus hydrocolloid occlusive dressing in the treatment of pressureulcers: a comparative, randomised, multicentre study Cost, efficacy, efficiency and tolerability of collagenase ointment versus hydrocolloid occlusive dressing in the treatment of pressureulcers: a comparative, randomised, multicentre study Cost, efficacy, efficiency and tolerability of collagenase ointment versus hydrocolloid occlusive dressing (...) in the treatment of pressureulcers: a comparative, randomised, multicentre study Burgos A, Gimenez J, Moreno E, Lamberto E, Utrera M, Urraca E M, Velez F J, Lopez E, Martinez M A, Gomez M J, Garcia L Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health
[A comparison of the effectiveness and cost of moist environment dressings treatment as compared to traditional dressings treatment: randomized clinical trial on patients suffering venous leg ulcers or pressureulcers treated by primary health care nurses Comparacion de la efectividad y coste de la cura en ambiente humedo frente a la cura tradicional: ensayo clinico en pacientes de atencion primaria con ulceras vasculares y por presion [A comparison of the effectiveness and cost of moist (...) environment dressings treatment as compared to traditional dressings treatment: randomized clinical trial on patients suffering venous leg ulcers or pressureulcers treated by primary health care nurses] Comparacion de la efectividad y coste de la cura en ambiente humedo frente a la cura tradicional: ensayo clinico en pacientes de atencion primaria con ulceras vasculares y por presion [A comparison of the effectiveness and cost of moist environment dressings treatment as compared to traditional dressings
The economics of preventing and treating pressureulcers: a pilot study The economics of preventing and treating pressureulcers: a pilot study The economics of preventing and treating pressureulcers: a pilot study Thomson J S, Brooks R G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology A potential prevention programme in patients with pressureulcers. The prevention programme would consist of additional specialist preventative equipment and access to a specialist tissue viability nurse. Type of intervention Secondary prevention; treatment. Economic study type Cost-effectiveness analysis. Study population Patients presenting with pressureulcers (geriatric inpatients). Setting Hospital. The economic analysis
Pressureulcer prevention: a randomized controlled trial of 2 risk-directed strategies for patient surface assignment Pressureulcer prevention: a randomized controlled trial of 2 risk-directed strategies for patient surface assignment Pressureulcer prevention: a randomized controlled trial of 2 risk-directed strategies for patient surface assignment Inman K J, Dymock K, Fysh N, Robbins B, Rutledge F S, Sibbald W J Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Two programmes of patient surface assignment for the prevention of pressureulcers (PUs) in the intensive care unit (ICU) were compared. One of the programmes emphasised the use of purchased products (experimental group), while the other relied on both purchased
Cost-effectiveness of an intensive pressureulcer prevention protocol in long-term care Cost-effectiveness of an intensive pressureulcer prevention protocol in long-term care Cost-effectiveness of an intensive pressureulcer prevention protocol in long-term care Xakellis G C, Frantz R A, Lewis A, Harvey P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Implementation of an intensive pressureulcer prevention protocol, in a long-term-care facility, using low-technology interventions such as foam overlays, heel protectors, and repositioning schedules in the prevention of pressureulcers. The intensity of the interventions increased incrementally as the subject's risk level increased. The Braden Scale for Predicting Pressure
The cost-effectiveness of interventions for preventing pressureulcers The cost-effectiveness of interventions for preventing pressureulcers The cost-effectiveness of interventions for preventing pressureulcers Xakellis G C, Frantz R A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology Frequent patient repositioning and use of pressure-reducing devices in prevention of pressureulcers. Type of intervention Primary prevention. Economic study type Cost-effectiveness analysis. Study population Elderly hospitalised patients. Setting Nursing home. The economic study was conducted in Moline, Illinois, USA. Dates to which data relate The effectiveness data were collected in 1991 for the intervention group and in 1960
A literature assessment of the use of miscellaneous topical agents, growth factors, and skin equivalents for the treatment of pressureulcers A literature assessment of the use of miscellaneous topical agents, growth factors, and skin equivalents for the treatment of pressureulcers A literature assessment of the use of miscellaneous topical agents, growth factors, and skin equivalents for the treatment of pressureulcers Margolis D J, Lewis V L Authors' objectives To review the efficacy (...) , Lewis V L. A literature assessment of the use of miscellaneous topical agents, growth factors, and skin equivalents for the treatment of pressureulcers. Dermatologic Surgery 1995; 21(2): 145-148 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Administration, Topical; Anti-Ulcer Agents /administration & Dermatologic Agents /administration & Growth Substances /administration & Humans; PressureUlcer /drug therapy; Randomized Controlled Trials as Topic; Skin, Artificial; dosage; dosage
A randomized trial of low-air-loss beds for treatment of pressureulcers. To assess the effectiveness of low-air-loss beds for the treatment of pressureulcers in nursing homes.Prospective, randomized, clinical trial.Three teaching nursing homes in Los Angeles, Calif.Eighty-four nursing home residents with trunk or trochanter pressureulcers (Shea stage > or = 2).Subjects were randomly assigned to use either a low-air-loss bed (n = 43) or a 10-cm corrugated foam mattress (n = 41) throughout (...) substantial improvement compared with foam mattresses despite other factors in pressureulcer healing.
Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressureulcers. To determine, in critically ill patients at risk, both the clinical utility and cost-effectiveness of using an air suspension bed in the prevention of pressure ulcers.Randomized, parallel group, controlled clinical trial with accompanying cost-effectiveness analysis.30-bed multidisciplinary intensive care unit.100 consecutive patients at risk for the development of pressureulcers randomly (...) assigned to receive treatment on either an air suspension bed or a standard intensive care unit bed. Patients considered at risk were those at least 17 years of age with an Acute Physiology and Chronic Health Evaluation II (APACHE II) score greater than 15 who had an expected intensive care unit stay of at least 3 days.The development of pressureulcers by site and severity and the costs associated with each of the two programs.The air suspension bed was associated with fewer patients developing single
Platelet-derived growth factor BB for the treatment of chronic pressureulcers. A randomised, phase I/II, double-blind, placebo-controlled study was designed to assess the effect of topically applied recombinant human BB homodimeric platelet-derived growth factor (rPDGF-BB) on healing of chronic pressureulcers. Twenty patients were randomly allocated daily treatment for 28 days with 1, 10, or 100 micrograms/ml rPDGF-BB (0.01, 0.1, or 1.0 micrograms per cm2 ulcer area) or placebo. Patients (...) treated with 100 micrograms/ml rPDGF-BB showed a greater healing response than the placebo group, but the lower doses had little effect. After 28 days, ulcers treated with 100 micrograms/ml rPDGF-BB were smaller than those treated with placebo (mean [SE] volume 6.4 [4.0] vs 21.8 [5.6]% of day 0 volume). There were no toxic effects. These preliminary findings suggest that rPDGF-BB is a potent wound-healing agent in soft tissue.